Edition 61 – Bringing Health Equity to the Forefront of Tobacco Product Regulation

Edition 61 – Bringing Health Equity to the Forefront of Tobacco Product Regulation

Bringing Health Equity to the Forefront of Tobacco Product Regulation By Brian A. King, PhD, MPH (he/him/his) Facebook Twitter LinkedIn Citation Bringing Health Equity to the Forefront of Tobacco Product Regulation. HPHR. 2022;61. https://doi.org/10.54111/0001/III2 Bringing Health Equity to the Forefront of Tobacco Product Regulation Downloadable PDF Edition 61 – Bringing Health Equity To The Forefront […]

Edition 56 – Legislating the New Gilead: Implications of the Texas Heartbeat Act

Legislating the New Gilead: Implications of the Texas Heartbeat Act

Legislating the New Gilead: Implications of the Texas Heartbeat Act By Heather Tillewein, PhD, CHES, Abdul-Rahman Toufik, Wireko Andrew Awuah, Yves Miel H. Zuñiga, Duha Shellah, Alice Colescu, Candice Danielle Carpenter, MD, MBA, MPH, EdM, Circe Gray Le Compte, ScD, SM, Share on facebook Facebook Share on twitter Twitter Share on linkedin LinkedIn Citation Tillewein […]

Edition 54 – The Evaluation of Pro-competitive Policies Effectiveness from Taxed-based and Privatized Health Insurance Models

Edition 54 – The Evaluation of Pro-competitive Policies Effectiveness from Taxed-based and Privatized Health Insurance Models

The Evaluation of Pro-Competitive Policies Effectiveness From Taxed-Based and Privatized Health Insurance Models By Todd Brown, MSc. Facebook Twitter LinkedIn Citation Brown T. The evaluation of pro-competitive policies effectiveness from taxed-based and privatized health insurance models. HPHR. 2022;54. 10.54111/0001/BBB5 The Evaluation of Pro-Competitive Policies Effectiveness From Taxed-Based and Privatized Health Insurance Models Abstract Introduction Healthcare […]

Edition 54 – Innovation Immersion Labs: A Novel Approach to Solving Public Health Challenges

Edition 54 – Innovation Immersion Labs: A Novel Approach to Solving Public Health Challenges

Innovation Immersion Labs: A Novel Approach to Solving Public Health Challenges By Liris Stephanie Berra, BS, Sophie Becker, BFA, Meaghan Kennedy, MPH Facebook Twitter LinkedIn Citation Berra L, Becker S, Kennedy M. Innovation immersion labs: a novel approach to solving public health challenges. HPHR. 2022;54. 10.54111/0001/BBB4 Innovation Immersion Labs: A Novel Approach to Solving Public […]

Edition 56 – Year-to-Year Comparison of Virginia’s Hepatitis Education and Patient Connection Referral on Release Program Outcomes for those Recently Released from Incarceration

Edition 56 – Year-to-Year Comparison of Virginia’s Hepatitis Education and Patient Connection Referral on Release Program Outcomes for those Recently Released from Incarceration

Year-to-Year Comparison of Virginia’s Hepatitis Education and Patient Connection Referral on Release Program Outcomes for those Recently Released from Incarceration By Dr. Sylvia A.B. Caldwell, DHSc, MPH; Terry Knick-Kemp, MPH, BSN-BC; Dr. Rebecca Dillingham, MD, MPH; Dr. Jamie Smith, PharmD; Dr. Trey Fuller, PharmD, Share on facebook Facebook Share on twitter Twitter Share on linkedin […]

Edition 54 – Evaluation of Cancer Awareness Months and Cancer Screening Tests Through Internet Search Big Data

Evaluation of Cancer Awareness Months and Cancer Screening Tests Through Internet Search Big Data​

Evaluation of Cancer Awareness Months and Cancer Screening Tests Through Internet Search Big Data By Alex Vanderwiel, Diamone Gathers, MD, V. Shane Pankratz, PhD, Mikaela Kosich, MPH, Bernard Tawfik, MD Facebook Twitter LinkedIn Citation Goodman M. Potential economic burden contributing to treatment nonadherence in end-stage renal disease . HPHR. 2022;54. 10.54111/0001/BBB3 Potential Economic Burden Contributing […]

Edition 54 –Potential Economic Burden Contributing to Treatment Non-Adherence in End-Stage Renal Disease

Edition 54 –Potential Economic Burden Contributing to Treatment Nonadherence in End-Stage Renal Disease

Potential Economic Burden Contributing to Treatment Non-Adherence in End Stage Renal Disease By Max Goodman Facebook Twitter LinkedIn Citation Goodman M. Potential economic burden contributing to treatment nonadherence in end-stage renal disease . HPHR. 2021;54. 10.54111/0001/BBB2 Potential Economic Burden Contributing to Treatment Non-Adherence in End Stage Renal Disease Abstract There are over 750,000 patients in […]